-
Trial supports use of fluvoxamine in patients with mild COVID-19
europeanpharmaceuticalreview
October 16, 2020
A clinical trial has demonstrated that the likelihood of hospitalisation was significantly reduced for patients with mild COVID-19 when given fluvoxamine.
-
Immunotherapies to treat cervical cancer show promise in Phase II trials
europeanpharmaceuticalreview
October 16, 2020
Novel programmed cell death protein 1 immunotherapies for cervical cancer have demonstrated success in two Phase II clinical trials in the US.
-
J&J COVID-19 vaccine trial paused due to unexplained illness in participant
expresspharma
October 15, 2020
The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board, as well as the company's clinical and safety physicians, informed J&J.
-
COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment
expresspharma
October 15, 2020
Trials impacted by enrolment suspension have been on a downward trajectory, while the number of clinical trials with delayed initiation have remained steady.
-
FDA Awards Grants for Rare Diseases Clinical Trials
americanpharmaceuticalreview
October 15, 2020
The U.S. Food and Drug Administration (FDA) has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over the next four years.
-
Bharat Biotech told to provide phase II data of Covaxin before phase III trial
expresspharma
October 12, 2020
The SEC also observed that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported so far.
-
US FDA awards six clinical trials research grants to develop medical products for rare diseases
expresspharma
October 10, 2020
FDA received 47 clinical trial grant applications that were reviewed and evaluated for scientific and technical merit by more than 90 rare disease and clinical trial experts.
-
HHS Funds Development of Needle-free Vax Technology
contractpharma
October 10, 2020
Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.
-
BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services
contractpharma
October 10, 2020
Will support new medical countermeasure research in the fight against emerging infectious disease.
-
Sosei Heptares scores $5m milestone payment from Pfizer
pharmatimes
October 09, 2020
Sosei Heptares has received a $5m milestone payment from its strategic alliance partner Pfizer after the first subject in a clinical trial was dosed with a new drug candidate from the collaboration between the two companies.